UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 67

Sortiert nach

Clinical pharmacology and mechanism of action of zonisamide

Clinical neuropharmacology, 2007-07, Vol.30 (4), p.230-240

Biton, Victor

2007

Link zum Volltext

Verfügbarkeit prüfen

Brivaracetam as adjunctive treatment for uncontrolled partial epilepsy in adults: A phase III randomized, double‐blind, placebo‐controlled trial

Epilepsia (Copenhagen), 2014-01, Vol.55 (1), p.57-66

2014

Link zum Volltext

Verfügbarkeit prüfen

Pharmacokinetics, toxicology and safety of lamotrigine in epilepsy

Expert opinion on drug metabolism & toxicology, 2006-12, Vol.2 (6), p.1009-1018

Biton, Victor

2006

Link zum Volltext

Verfügbarkeit prüfen

A randomized, double‐blind, placebo‐controlled, parallel‐group study of rufinamide as adjunctive therapy for refractory partial‐onset seizures

Epilepsia (Copenhagen), 2011-02, Vol.52 (2), p.234-242

2011

Link zum Volltext

Verfügbarkeit prüfen

Lacosamide for the treatment of partial-onset seizures

Expert review of neurotherapeutics, 2012-06, Vol.12 (6), p.645-655

Biton, Victor

2012

Link zum Volltext

Verfügbarkeit prüfen

Tolerability and efficacy of adjunctive brivaracetam in adults with focal seizures by concomitant antiseizure medication use: Pooled results from three phase 3 trials

Epilepsia (Copenhagen), 2022-08, Vol.63 (8), p.2024-2036

2022

Link zum Volltext

Verfügbarkeit prüfen

Post hoc analysis of a phase 3 study for treatment of uncontrolled focal seizures: Adjunctive cenobamate dose and seizure reduction by baseline seizure frequency

Epilepsy research, 2022-10, Vol.186, p.107014-107014, Article 107014

2022

Link zum Volltext

Verfügbarkeit prüfen

Effect of antiepileptic drugs on bodyweight: Overview and clinical implications for the treatment of epilepsy

CNS drugs, 2003, Vol.17 (11), p.781-791

BITON, Victor

2003

Link zum Volltext

Verfügbarkeit prüfen

Perampanel as monotherapy or first adjunctive therapy in pediatric and adult patients with epilepsy: the first United States-based phase IV open-label ELEVATE study

Journal of neurology, 2024-07, Vol.271 (7), p.4587-4598

2024

Link zum Volltext

Verfügbarkeit prüfen

Long‐term individual retention with cenobamate in adults with focal seizures: Pooled data from the clinical development program

Epilepsia (Copenhagen), 2022-01, Vol.63 (1), p.139-149

2022

Link zum Volltext

Verfügbarkeit prüfen

Lacosamide as adjunctive therapy for partial‐onset seizures: A randomized controlled trial

Epilepsia (Copenhagen), 2010-06, Vol.51 (6), p.958-967

2010

Link zum Volltext

Verfügbarkeit prüfen

Topiramate titration and tolerability

The Annals of pharmacotherapy, 2001-02, Vol.35 (2), p.173

2001

Link zum Volltext

Verfügbarkeit prüfen

Safety and tolerability of lacosamide as adjunctive therapy for adults with partial-onset seizures: Analysis of data pooled from three randomized, double-blind, placebo-controlled clinical trials

Epilepsy & behavior, 2015-11, Vol.52 (Pt A), p.119-127

2015

Link zum Volltext

Verfügbarkeit prüfen

Final results from a Phase 3, long‐term, open‐label, repeat‐dose safety study of diazepam nasal spray for seizure clusters in patients with epilepsy

Epilepsia (Copenhagen), 2021-10, Vol.62 (10), p.2485-2495

2021

Link zum Volltext

Verfügbarkeit prüfen

Safety and tolerability of adjunctive brivaracetam as intravenous infusion or bolus in patients with epilepsy

Epilepsia (Copenhagen), 2016-07, Vol.57 (7), p.1130-1138

2016

Link zum Volltext

Verfügbarkeit prüfen

Efficacy and Safety of Oral Lacosamide as Adjunctive Therapy in Adults with Partial‐Onset Seizures

Epilepsia (Copenhagen), 2007-07, Vol.48 (7), p.1308-1317

2007

Link zum Volltext

Verfügbarkeit prüfen

Post hoc analysis of a phase 3, multicenter, open‐label study of cenobamate for treatment of uncontrolled focal seizures: Effects of dose adjustments of concomitant antiseizure medications

Epilepsia (Copenhagen), 2021-12, Vol.62 (12), p.3016-3028

2021

Link zum Volltext

Verfügbarkeit prüfen

A randomized phase 2b efficacy study in patients with seizure episodes with a predictable pattern using Staccato® alprazolam for rapid seizure termination

Epilepsia (Copenhagen), 2023-02, Vol.64 (2), p.374-385

2023

Link zum Volltext

Verfügbarkeit prüfen

Efficacy of cenobamate for uncontrolled focal seizures: Post hoc analysis of a Phase 3, multicenter, open‐label study

Epilepsia (Copenhagen), 2021-12, Vol.62 (12), p.3005-3015

2021

Link zum Volltext

Verfügbarkeit prüfen

Long‐term safety and efficacy of lacosamide and controlled‐release carbamazepine monotherapy in patients with newly diagnosed epilepsy

Epilepsia (Copenhagen), 2019-12, Vol.60 (12), p.2437-2447

2019

Link zum Volltext

Verfügbarkeit prüfen

Long‐term safety, efficacy, and quality of life outcomes with adjunctive brivaracetam treatment at individualized doses in patients with epilepsy: An up to 11‐year, open‐label, follow‐up trial

Epilepsia (Copenhagen), 2020-04, Vol.61 (4), p.636-646

2020

Link zum Volltext

Verfügbarkeit prüfen

Lacosamide for the treatment of diabetic neuropathic pain

Expert review of neurotherapeutics, 2008-11, Vol.8 (11), p.1649-1660

Biton, Victor

2008

Link zum Volltext

Verfügbarkeit prüfen

Evaluation of diazepam nasal spray in patients with epilepsy concomitantly using maintenance benzodiazepines: An interim subgroup analysis from a phase 3, long‐term, open‐label safety study

Epilepsia (Copenhagen), 2021-06, Vol.62 (6), p.1442-1450

2021

Link zum Volltext

Verfügbarkeit prüfen

Bioequivalence of oral and intravenous carbamazepine formulations in adult patients with epilepsy

Epilepsia (Copenhagen), 2015-06, Vol.56 (6), p.915-923

2015

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 67

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(64)
Mit Volltextzugriff
(61)

Publikationsform

Artikel
(65)
Buchkapitel
(2)

Sprache

Englisch
(67)
Japanisch
(6)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(55)
Science & Technology
(55)
Humans
(50)
Clinical Neurology
(46)
Neurosciences & Neurology
(46)
Epilepsy
(35)
Adult
(34)
Female
(33)
Male
(33)
Treatment Outcome
(31)
Middle Aged
(30)
Double-Blind Method
(29)
Anticonvulsants - Therapeutic Use
(22)
Adolescent
(21)
Anticonvulsants - Adverse Effects
(20)
Aged
(18)
Epilepsy - Drug Therapy
(18)
Anticonvulsants - Administration & Dosage
(17)
Neurology
(17)
Biological And Medical Sciences
(16)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Clinical pharmacology and mechanism of action of zonisamide

Brivaracetam as adjunctive treatment for uncontrolled partial epilepsy in adults: A phase III randomized, double‐blind, placebo‐controlled trial

Pharmacokinetics, toxicology and safety of lamotrigine in epilepsy

A randomized, double‐blind, placebo‐controlled, parallel‐group study of rufinamide as adjunctive therapy for refractory partial‐onset seizures

Consistent safety and tolerability of Valtoco® (diazepam nasal spray) in relationship to usage frequency in patients with seizure clusters: Interim results from a phase 3, long‐term, open‐label, repeat‐dose safety study

Lacosamide for the treatment of partial-onset seizures

Tolerability and efficacy of adjunctive brivaracetam in adults with focal seizures by concomitant antiseizure medication use: Pooled results from three phase 3 trials

Post hoc analysis of a phase 3 study for treatment of uncontrolled focal seizures: Adjunctive cenobamate dose and seizure reduction by baseline seizure frequency

Effect of antiepileptic drugs on bodyweight: Overview and clinical implications for the treatment of epilepsy

Perampanel as monotherapy or first adjunctive therapy in pediatric and adult patients with epilepsy: the first United States-based phase IV open-label ELEVATE study

Long‐term individual retention with cenobamate in adults with focal seizures: Pooled data from the clinical development program

Lacosamide as adjunctive therapy for partial‐onset seizures: A randomized controlled trial

Topiramate titration and tolerability

Safety and tolerability of lacosamide as adjunctive therapy for adults with partial-onset seizures: Analysis of data pooled from three randomized, double-blind, placebo-controlled clinical trials

Final results from a Phase 3, long‐term, open‐label, repeat‐dose safety study of diazepam nasal spray for seizure clusters in patients with epilepsy

Safety and tolerability of adjunctive brivaracetam as intravenous infusion or bolus in patients with epilepsy

Efficacy and Safety of Oral Lacosamide as Adjunctive Therapy in Adults with Partial‐Onset Seizures

Post hoc analysis of a phase 3, multicenter, open‐label study of cenobamate for treatment of uncontrolled focal seizures: Effects of dose adjustments of concomitant antiseizure medications

A randomized phase 2b efficacy study in patients with seizure episodes with a predictable pattern using Staccato® alprazolam for rapid seizure termination

Efficacy of cenobamate for uncontrolled focal seizures: Post hoc analysis of a Phase 3, multicenter, open‐label study

Long‐term safety and efficacy of lacosamide and controlled‐release carbamazepine monotherapy in patients with newly diagnosed epilepsy

Long‐term safety, efficacy, and quality of life outcomes with adjunctive brivaracetam treatment at individualized doses in patients with epilepsy: An up to 11‐year, open‐label, follow‐up trial

Lacosamide for the treatment of diabetic neuropathic pain

Evaluation of diazepam nasal spray in patients with epilepsy concomitantly using maintenance benzodiazepines: An interim subgroup analysis from a phase 3, long‐term, open‐label safety study

Bioequivalence of oral and intravenous carbamazepine formulations in adult patients with epilepsy

Suchergebnisse filtern